Podcasts
Discussing Effectiveness, Persistence Rates for Atopic Dermatitis Therapy
08/13/2020
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues sought to better describe adult patients with atopic dermatitis initiating dupilumab treatment in a clinical practice setting, with regard to socio-demographic characteristics, comorbidity, treatment patterns, and persistence.
References:- Silverberg JI, Guttman-Yassky E, Gadkari A, et al. Real-world persistence with dupilumab among adults with atopic dermatitis (AD). Poster presented at: The Society for Investigative Dermatology (SID) 77th Annual Meeting; May 8–11, 2019; Chicago, IL.
- Silverberg JI, Guttman-Yassky E, Gadkari A, et al. Real-world persistence with dupilumab among adults with atopic dermatitis (AD). Oral presentation at: The Society for Investigative Dermatology (SID) 77th Annual Meeting; May 8–11, 2019; Chicago, IL.
Current Issue
September 2024
Volume 21
Issue 3
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter